PPBT
Purple Biotech
PPBT
PPBT
5 hedge funds and large institutions have $43K invested in Purple Biotech in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
$9K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
$20K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
$0 |
| 3 |
UBS Group
Zurich,
Switzerland
|
$1K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $20K | -$21.3K | -150 | -52% |
|
|
KWM
2
Kingsview Wealth Management
Grants Pass,
Oregon
| $12K | – | – | – |
|
|
VF
3
Virtu Financial
New York
| $9K | +$9K | +59 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| $1K | -$400 | -2 | -29% |
|
|
ASN
5
Advisory Services Network
Atlanta,
Georgia
| $1K | – | – | – |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| – | -$14K | -73 | Closed |
|